Skip to main content
. 2013 Feb 13;15(4):469–479. doi: 10.1093/neuonc/nos317

Fig. 1.

Fig. 1.

Distribution of biomarkers in the studied population with LGG. (A) Frequencies of IDH1 and IDH2 mutations by tumor histology; (B) distribution plot of percentages of methylated MGMT promoter in individual IDH-mutant LGG (left), association between IDH mutation (IDH1 or IDH2), and MGMT promoter methylation (right).